ICD-10-CM Billable Code

M1A.20

Drug-induced chronic gout, unspecified site

Clinical Classification Guidelines

Medical Intelligence & Overview

Drug-induced chronic gout is a condition characterized by persistent joint inflammation caused by the accumulation of uric acid crystals, which is triggered or worsened by certain medications. While gout is commonly linked to dietary and genetic factors, some medications can lead to chronic gout, especially when used over a long period. The ICD-10 code M1A.20 categorizes cases where drugs are identified as the cause of the persistent gout, with no specific site of inflammation specified. This condition requires careful management to prevent joint damage and maintain quality of life.

Causes & Symptoms

Clinical Causes: Use of medications known to increase uric acid levels or impair its excretion, such as diuretics, low-dose aspirin, or certain immunosuppressants. Prolonged use of drugs that interfere with uric acid metabolism. Underlying renal impairment that reduces the body's ability to eliminate uric acid, exacerbated by some medications. Interactions between multiple drugs that collectively raise uric acid levels.

Key Symptoms: Persistent joint pain, especially in the big toe, but also in other joints such as the ankles, knees, or wrists. Swelling and redness around affected joints. Recurrent episodes of joint inflammation that may become more frequent over time. Development of tophi, which are deposits of uric acid crystals under the skin, in chronic cases. Limited joint mobility due to ongoing inflammation and joint damage.

Diagnostic & Treatment

Diagnosis Path: The diagnosis of drug-induced chronic gout typically involves a combination of medical history, physical examination, and laboratory tests. Relevant steps include: - Reviewing medication history to identify drugs associated with hyperuricemia. - Blood tests to measure serum uric acid levels, which tend to be elevated. - Joint fluid analysis, often using joint aspiration, to identify uric acid crystals under microscopy. - Imaging studies like ultrasound or X-rays to assess joint damage and presence of tophi. The diagnosis is confirmed when persistent symptoms coincide with a history of medication use known to induce gout, and other causes of joint inflammation are ruled out.

Treatment Protocols: Managing drug-induced chronic gout involves guiding the patient through several strategies: - Reviewing and adjusting medications with healthcare providers to minimize impact on uric acid levels. - Use of urate-lowering therapies such as allopurinol or febuxostat to reduce serum uric acid concentrations. - Anti-inflammatory medications like nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids to manage acute flare-ups. - Lifestyle modifications, including dietary changes to reduce purine intake, weight management, and hydration. - Regular monitoring of uric acid levels to evaluate treatment efficacy. - Addressing underlying renal conditions if present, to improve uric acid excretion. A comprehensive approach tailored to individual needs can help prevent joint damage and improve the patient's quality of life.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M1A.20 a billable ICD-10 code?
Yes, M1A.20 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M1A.20?
Clinical documentation must specify the nature of Drug-induced chronic gout, unspecified site and any associated comorbidities for accurate reporting.

Cite this Clinical Reference